Last updated on April 16, 2014 at 5:49 EDT

Latest Vital Access Corp. Stories

2013-09-20 16:24:23

ORANGEBURG, S.C. and SALT LAKE CITY, Sept. 20, 2013 /PRNewswire/ -- Vital Access today announced the first U.S. commercial implantation of their VWING(TM) Vascular Needle Guide, in a patient presenting with cannulation challenges and with difficulties in achieving ideal dialysis access due to the depth and tortuosity of their AV fistula. The VWING Vascular Needle Guide was recently granted FDA market approval following completion of a multi-center, prospective clinical study....

2013-09-16 16:24:20

SALT LAKE CITY, Sept. 16, 2013 /PRNewswire/ -- Vital Access Corp. today announced that it has received U.S. Food and Drug Administration (FDA) market clearance for its patented VWING(TM) Vascular Needle Guide which has been shown to enable vascular access to arteriovenous fistulas (AVF) for patients undergoing hemodialysis. Kidney failure affects millions of people worldwide, and hemodialysis via an autologous arteriovenous fistula (AVF) is the global gold standard for patients...